Understanding Gestational Diabetes Mellitus (GDM)

Gestational diabetes mellitus is a form of hyperglycemia first diagnosed during pregnancy, typically between weeks 24 and 28. During gestation, the placenta secretes hormones (including human placental lactogen, estrogen, and cortisol) that promote fetal nourishment by naturally increasing maternal insulin resistance. When maternal pancreatic beta-cells cannot produce sufficient insulin to overcome this counter-regulatory surge, blood glucose levels rise.

Risk Factors for Gestational Diabetes

  • Pre-pregnancy body mass index (BMI) in the overweight or obese category.
  • Family history of type 2 diabetes mellitus in first-degree relatives.
  • History of gestational diabetes or delivering an infant weighing over 4 kg in prior pregnancies.
  • Polycystic ovary syndrome (PCOS) or pre-existing metabolic syndrome.

Diagnostic Screening

Standard screening involves the Oral Glucose Tolerance Test (OGTT), usually conducted between 24 and 28 weeks of gestation. Blood glucose is assessed while fasting, followed by measurements 1 and 2 hours after consuming a standardized 75g glucose solution.

Safe Management and Nutritional Protocol

  1. Complex Carbohydrate Distribution: Replace refined sugars with low glycemic index whole grains, legumes, and fresh vegetables distributed evenly across 3 main meals and 2 healthy snacks.
  2. Daily Blood Glucose Monitoring: Measure fasting blood glucose upon waking (target < 95 mg/dL) and 1-hour or 2-hour postprandial readings (targets < 140 mg/dL and < 120 mg/dL respectively).
  3. Safe Physical Activity: 20 to 30 minutes of daily low-impact walking improves peripheral insulin sensitivity safely during pregnancy.
  4. Pharmacological Support: When medical nutrition therapy does not achieve target glycemic ranges, safe insulin therapy is introduced under close endocrinological supervision to safeguard fetal growth.